Furthermore, we conducted a comparative analysis of baseline LARGE1 levels in serum samples derived from pediatric and adult patients with SMA against the serum LARGE1 levels observed in various other neuromuscular disorders (NMD). The gene discussed is LARGE1; the disease is proximal spinal muscular atrophy.